Raising awareness of NSW MedTech capability
Leading NSW electronics designer Genesys welcomes the NSW government’s drive to improve connectivity and collaboration within the NSW medical technology industry.
Contained in the NSW Medical Technology Industry Development Strategy 2018, released this week, it is a call to rebuild advanced manufacturing capability in NSW.
“Negative stories about manufacturing decline over the years has cultivated a perception in Australia that the capacity to develop advanced products has disappeared,” says Geoff Sizer, CEO at Genesys Electronics Design.
“However, nothing is further from the truth. In recent years a network of companies in NSW has been steadily building their capacity to build complex medical devices to the highest possible quality standard,” Sizer says.
Genesys and some trusted partners have all gained ISO 13485 medical-grade quality certification. Key ISO 13485 certified partners include Design & Industry, delivering industrial design, and Circuitwise delivering assembled printed circuit boards and final product assembly. Specialising without compromise, these companies together provide best-in-class medical product development from concept to boxed product.
“I have noticed there seems to be a general lack of awareness of the growing capability in NSW to develop complex medical devices,” Sizer says.
“Beyond our key partners, there is a large range of competent suppliers to the MedTech industry ranging from precision mechanical manufacturing, sterilised assembly and packaging, electromagnetic compatibility testing, regulatory compliance consulting and so forth.”
There is a general lack of awareness of the growing capability in NSW to develop complex medical devices
Sizer particularly welcomes the strategy’s initiative to map and showcase the medical technology sector, which he says is long overdue. This initiative aims to increase awareness among small to medium-sized enterprises of the skills and capacities across the NSW MedTech industry.
A related initiative has been the establishment of Fledge Innovation Labs, “providing medical technology businesses with low-cost access to collaborative working spaces, laboratory facilities, scientific equipment, and business support”, according to the strategy paper.
Genesys is supporting this initiative by making its expert staff available as advisors to Fledge and the start-up business operating there.
Sizer was also pleased to see the statistic that NSW is home to 37% of medical business in Australia, by state, revealing the depth of expertise right here in NSW. The strategy suggests that the industry could grow from $4.8 billion GDP today, employing around 7000 people, to over $18 billion with 28,000 by 2025.
“This statistic shows the prize if there is a coordinated effort to build NSW capacity in advanced manufacturing. We should all get behind this effort.”
24 October 2018
For further information contact:
Dr Tim Kannegieter Marketing Manager Genesys Electronics Design email@example.com